ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BLFS BioLife Solutions Inc

21.68
-0.15 (-0.69%)
After Hours
Last Updated: 22:30:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
BioLife Solutions Inc NASDAQ:BLFS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.15 -0.69% 21.68 20.50 22.00 21.81 21.25 21.67 235,167 22:30:00

BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024

30/04/2024 9:12pm

PR Newswire (US)


BioLife Solutions (NASDAQ:BLFS)
Historical Stock Chart


From May 2024 to May 2024

Click Here for more BioLife Solutions Charts.

BOTHELL, Wash., April 30, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's first quarter 2024 financial results will be released after market close on Thursday, May 9, 2024. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update.

BioLife Solutions New Logo 2021 (PRNewsfoto/BioLife Solutions, Inc.)

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free 1-877-346-6112 or 1-848-280-6350 for international callers. A webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com for 90 days.

About BioLife Solutions
BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.

Media & Investor Relations

At the Company
Troy Wichterman 
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com 

Investors
LHA Investor Relations
Jody Cain
(310) 691-7100
jcain@lhai.com  

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-first-quarter-2024-financial-results-and-business-update-on-may-9-2024-302132232.html

SOURCE BioLife Solutions, Inc.

Copyright 2024 PR Newswire

1 Year BioLife Solutions Chart

1 Year BioLife Solutions Chart

1 Month BioLife Solutions Chart

1 Month BioLife Solutions Chart

Your Recent History

Delayed Upgrade Clock